跳至主要内容
临床试验/NCT01555073
NCT01555073终止4 期

A Prospective Randomized Blinded Placebo Controlled Comparison of Multimodal Pre-emptive Analgesia on Long Term Outcome Following Uterine Artery Embolization

Northwestern University1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
23
试验地点
1
主要终点
Post Operative Pain Control

研究概览

简要总结

Uterine leiomyomata, also known as fibroids, are an extremely common benign lesion being present in 30-50% of all women. Traditional surgical treatment of symptomatic fibroids has been hysterectomy in post child bearing woman. However, over the last decade, the use of a minimal invasive technique called uterine artery embolization has become increasingly popular due to high patient satisfaction, cost effectiveness, and shorter recovery period. The purpose of this randomized blinded placebo controlled study is to compare pre-emptive analgesia vs non-preemptive analgesia for immediate postoperative pain control, long term pain control, and improved quality of life in woman following uterine artery embolization surgery. The study consists of four drug groups including a placebo group. The addition of pregabalin and celecoxib together with epidural analgesia may improve pain management as well as leading to a better post-procedure outcome in women following uterine artery embolization.

Many investigators believe that the ischemia in the normal myometrium is the primary source of pain immediately following surgery making postoperative pain management challenging. Epidural fentanyl may offer an advantage when encountering visceral pain. In addition to being an effective analgesic for chronic pain syndromes, the use of pregabalin provides effective postoperative analgesia when it is administered pre-emptively before an operation. Preemptive analgesia involves the introduction of an analgesic regimen before the onset of noxious stimuli, with the goal of preventing sensitization of the nervous system to subsequent stimuli that could amplify pain. In human trials, pregabalin has been demonstrated to reduce pain, improve sleep, and mood disturbances in patients with post herpetic neuralgia. The use of celecoxib in combination with pregabalin has shown to provide more effective analgesia by providing antihyperalgesia. Therefore, the addition of pregabalin and celecoxib together with epidural analgesia may improve pain management as well as having an effect on long term sequelae.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult female patients (>18 years of age) who are undergoing elective uterine artery embolization will be included in the study.

排除标准

  • Exclusion criteria for the study are patient refusal to be included in the study, the presence of language barrier that inhibits proper communication with the patient
  • Contraindications to regional anesthesia
  • History of allergy to amide local anesthetics or narcotics
  • Known hypersensitivity to pregabalin, creatinine clearance ≤ 60 mL/min
  • The presence of a progressive neurological deficit
  • The presence of chronic opioid analgesia
  • The presence of a coagulopathy or infection, pregnancy
  • Patients with cardiovascular disease
  • Patients who take daily antiplatelet medications, patients with peptic ulcer disease
  • History of psychiatric disorder or inability to follow study protocol.
  • Dropout criteria include failed epidural analgesia, inability to tolerate side effects (nausea) from pregabalin, and the inability to contact during follow up.

研究组 & 干预措施

Pregabalin/celecoxib group

Active Comparator

pregabalin/celecoxib twice a day for 13 days.

干预措施: pregabalin/celecoxib (Drug)

Pregabalin/placebo group

Active Comparator

pregabalin/placebo twice a day for 13 days.

干预措施: pregabalin/placebo (Drug)

Celecoxib/placebo group

Active Comparator

celecoxib/placebo twice a day for 13 days.

干预措施: celecoxib/placebo (Drug)

Placebo group

Placebo Comparator

Placebo group, two placebo tablets day of surgery and twice a day for 13 days

干预措施: Placebo group (Drug)

结局指标

主要结局

Post Operative Pain Control

时间窗: Expected average of 12 weeks

To evaluate the post operative pain control of the four groups in immediate postoperative period and months following uterine artery embolisation procedure.

次要结局

  • Quality of Life(Expected average of 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Antoun Nader

Professor in Anesthesiology and Orthopaedic Surgery

Northwestern University

研究点 (1)

Loading locations...

相似试验

Preemptive Analgesia Following Uterine Artery... | 临床试验